ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,088, issued on Jan. 28, was assigned to ARDELYX INC. (Fremont, Calif.).
"Hormone receptor modulators for treating metabolic conditions and disorders" was invented by Jianhua Chao (Fremont, Calif.), Rakesh Jain (Fremont, Calif.), Lily Hu (Fremont, Calif.), Jason Gustaf Lewis (Fremont, Calif.), Helene Baribault (Fremont, Calif.) and Jeremy Caldwell (Fremont, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I):wherein L1, A, X1, X2, R...